MO50-4 Efficacy and safety of commercially approved BCMA-targeting CAR-T therapy in triple-class refractory multiple myeloma
Titel:
MO50-4 Efficacy and safety of commercially approved BCMA-targeting CAR-T therapy in triple-class refractory multiple myeloma
Auteur:
Nishimura, Noriko Brown, Samantha Devlin Sean, M. Parastoo, Dahi Landau Heather, J. Lahoud Oscar, B. Michael, Scordo Shah Gunjan, L. Chung David, J. Hani, Hassoun Malin, Hultcrantz Neha, Korde Lesokhin Alexander, M. Sham, Mailankody Shah Urvi, A. Tan Carlyn, R. Usmani Saad, Z. Giralt, Sergio A.